Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The risk of cancer from azathioprine as a treatment for multiple sclerosis.
Neutrophil-related factors as biomarkers in EAE and MS.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
Differential Diagnosis for Multiple Sclerosis-related Optic Neuritis.
Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma.
Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties.
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.
Quantitative assessment of finger motor impairment in multiple sclerosis.
Optic neuritis and the evaluation of visual impairment in multiple sclerosis.
Calcium-phosphate metabolism in patients with multiple sclerosis.
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females.
Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models.
Teriflunomide and its mechanism of action in multiple sclerosis.
Onset symptoms in paediatric multiple sclerosis.
The node of Ranvier in CNS pathology.
Month of birth and risk of multiple sclerosis in Kuwait: A population-based registry study.
TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
Two assessments to evaluate imagery ability: translation, test-retest reliability and concurrent validity of the German KVIQ and Imaprax.

Pages